SEC Form 4 · accession 0001571049-16-013594
PHIBRO ANIMAL HEALTH CORP · PAHC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gerald K Carlson
Officer — Chief Operating Officer · Director
Period of report
Mar 31, 2016
Accepted (ET)
Apr 1, 2016 · 9:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001069899
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Mar 31, 2016 | M | 3,594 | $11.83 | A | 3,594 | D | |
| Class A Common StockF2 | Mar 31, 2016 | S | 3,594 | $27.03 | D | 0 | D | |
| Class A Common Stock | Apr 1, 2016 | M | 4,406 | $11.83 | A | 4,406 | D | |
| Class A Common StockF3 | Apr 1, 2016 | S | 4,406 | $27.01 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to purchase Class A Common Stock | $11.83 | Mar 31, 2016 | M | 3,594 | D | Apr 29, 2013 | Feb 28, 2019 | Class A Common Stock | 3,594 | 76,456 | D |
| Option to purchase Class A Common Stock | $11.83 | Apr 1, 2016 | M | 4,406 | D | Apr 29, 2013 | Feb 28, 2019 | Class A Common Stock | 4,406 | 72,050 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2015.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.00 to $27.14, inclusive.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.00 to $27.03, inclusive.